Stephen Chelberg is a partner in the international law firm of Squire, Patton Boggs based in Tokyo, where he serves as the leader of the firm’s global Life Sciences Group and as the Asia Pacific chair of the firm’s global Corporate Practice Group.

 

His practice focuses on cross-border corporate transactions, including public and private company mergers and acquisitions, divestitures, corporate restructurings, joint ventures, strategic alliances, venture capital, IPOs and financing projects for clients involved in a wide variety of sectors.

 

Stephen’s experience includes advising clients involved in the pharmaceutical, medical device, biotechnology, telecommunications, aerospace, software, computer hardware, semiconductor manufacturing and test equipment, iron and steel, machinery, transportation and chemical industries.

 

Stephen also has extensive experience advising clients on a wide variety of commercial and intellectual property transactions, including collaborative research and development agreements, acquisition of IP rights, licensing and distribution arrangements and international dispute resolution and corporate compliance and regulatory issues, including anti-bribery laws.

​

Twice in his career, Stephen took time out from the practice of law to establish and run, as president, two companies in Japan: Watkins-Johnson K.K., a semiconductor equipment manufacturer, and Manugistics Japan K.K., a supply chain software company.

​

Stephen serves on the governing body of the U.S. - Japan Healthcare Connection, a non-profit organization whose mission is to promote healthcare innovation through US-Japanese interaction in industry, academia and government. He is also an angel investor in life science companies and has mentored numerous start-up life science companies, including through Cambridge Innovation Center.